Condition: Carcinoma, Non-Small-Cell Lung · Sponsor: Hoffmann-La Roche
This study is a multicenter, prospective, cohort study designed to evaluate the clinical outcomes and characteristics of resected stage II-IIIB anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) adult patients treated with Alectinib as adjuvant therapy in China.
This description comes directly from the study's public registry record.
Reference Study ID Number: ML45766 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Affiliated Hospital of Guangdong Medical University | Zhanjiang, Guangdong, China | Recruiting |
| Affiliated Cancer Hospital and Institute of Guangzhou Medical University | Guangzhou, Guangzhou, China | Recruiting |
| Huai He Hospital of Henan University | Kaifeng, Henan, China | Recruiting |
| Henan Provincial Chest Hospital | Zhengzhou, Henan, China | Recruiting |
| The First Affiliated Hospital of Xinjiang Medical University | Ürümqi, Xinjiang, China | Recruiting |
| Peking University First Hospital | Beijing, China | Recruiting |
| Xuanwu Hospital, Capital Medical University | Beijing, China | Active Not Recruiting |
| Hunan Cancer Hospital | Changsha, China | Recruiting |
| Changzhou First People's Hospital | Changzhou, China | Recruiting |
| Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital | Chengdu, China | Recruiting |
| The First Affiliated Hospital, Chongqing Medical University | Chongqing, China | Recruiting |
| The Second Affiliated Hospital of Dalian Medical University | Dalian, China | Recruiting |
+ 32 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06862869